Literature DB >> 33408022

Referring to the study: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial.

Marcelo Rodrigues Dos Santos1.   

Abstract

Entities:  

Year:  2021        PMID: 33408022     DOI: 10.1016/j.ijantimicag.2020.106176

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  2 in total

1.  Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.

Authors:  Philippe Gautret; Jean-Christophe Lagier; Stéphane Honoré; Van Thuan Hoang; Philippe Colson; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2021-01       Impact factor: 5.283

2.  Response to advances statistical methods and designs for clinical trials for COVID-19.

Authors:  Philippe Gautret; Van Thuan Hoang; Jean-Christophe Lagier; Didier Raoult
Journal:  Int J Antimicrob Agents       Date:  2021-01       Impact factor: 5.283

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.